2133 POSTER The total fiscal UK costs of managing women with relapsed breast cancer – the strong economic case for adjuvant exemestane

R.Thomas; M.Williams; J.Glen; M.Callam

首页> 外文期刊>European Journal of Cancer Supplements >2133 POSTER The total fiscal UK costs of managing women with relapsed breast cancer – the strong economic case for adjuvant exemestane

【24h】

2133 POSTER The total fiscal UK costs of managing women with relapsed breast cancer – the strong economic case for adjuvant exemestane

机译：2133海报在英国，管理患有复发性乳腺癌的妇女的总财政费用–佐剂依西美坦的有力经济依据

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2007年第4期|共2页
作者
R.Thomas; M.Williams; J.Glen; M.Callam;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 2062 POSTER Comparison of the cost-effectiveness of upfront letrozole or anastrozole, or switched exemestane versus tamoxifen for early breast cancer in hormone receptor positive (HR+) postmenopausal women: the UK perspective [J] . F.Di Trapani, J.Karnon, S.Kaura European Journal of Cancer Supplements . 2007,第4期

机译：2062 POSTER比较绝经后激素受体阳性（HR +）妇女中的前期来曲唑或阿那曲唑或切换的依西美坦与他莫昔芬治疗早期乳腺癌的成本-效果比较
2. Exemestane in adjuvant treatment of early breast cancer in postmenopausal women: results of a UK cost-effectiveness model [J] . K.Wilson, Wordsworth, M.Tabberer, European Journal of Cancer Supplements . 2006,第2期

机译：依西美坦在绝经后妇女早期乳腺癌的辅助治疗中：英国成本效益模型的结果
3. The total hospital and community UK costs of managing patients with relapsed breast cancer [J] . R J Thomas, M Williams, C Marshall, British Journal of Cancer . 2009,第4期

机译：英国医院和社区管理复发性乳腺癌患者的总费用
4. Dietary associations with biomarkers of breast cancer risk in women on adjuvant tamoxifen therapy. [D] . Strom, Meghan Brianna. 2016

机译：辅助性他莫昔芬治疗妇女饮食中与乳腺癌风险生物标志物的关联。
5. The total hospital and community UK costs of managing patients with relapsed breast cancer [O] . R J Thomas, M Williams, C Marshall, 2009

机译：英国医院和社区管理复发性乳腺癌患者的总费用
6. The total hospital and community UK costs of managing patients with relapsed breast cancer [O] . Thomas, R J, Williams, M, Marshall, C, 2009

机译：英国医院和社区管理复发性乳腺癌患者的总费用

2133 POSTER The total fiscal UK costs of managing women with relapsed breast cancer – the strong economic case for adjuvant exemestane

著录项

相似文献

相关主题

期刊订阅